Skip to main content
. 2021 Dec 9;9:e12626. doi: 10.7717/peerj.12626

Table 2. Univariate and multivariate analysis of risk factors in training cohort.

Factors Univariate Multivariate
P OR (95% CI) P OR (95% CI)
Age ≥50y 0.034a 2.200 (1.060, 4.568) 0.007* 3.534 (1.414, 8.831)
Sex 0.084a 1.864 (0.909, 3.780) 0.180 1.804 (0.761, 4.276)
Gottron’s sign 0.286 0.682 (0.337, 1.379)
Periochia erythema 0.888 1.081 (0.365, 3.205)
Poikiloderma 0.077a 2.241 (0.916, 5.486) 0.051 2.890 (0.994, 8.407)
Refractory itching 0.014a 3.267 (1.274, 8.378) 0.013* 4.642 (1.375, 15.671)
V-neck sign 0.857 1.067 (0.527, 2.163)
Periorbital erythema 0.507 1.295 (0.603, 2.781)
Raynaud’s phenomenon >0.999 <0.001
Joint pain 0.165 0.408 (0.115, 1.449)
Proximal muscle weakness 0.769 0.892 (0.417, 1.908)
Dysphagia <0.001a 4.224 (1.932, 9.233) 0.003* 4.223 (1.617, 11.023)
Interstitial pneumonia 0.033a 0.440 (0.207, 0.936) 0.031* 0.367 (0.147, 0.913)
Respiration failure 0.250 0.546 (0.195, 1.531)
CK ≥198U/L 0.002a 3.137 (1.521, 6.467) 0.049* 2.306 (1.003, 5.304)
LDH ≥300U/L 0.784 0.905 (0.443, 1.847)
ANA (+) 0.316 0.696 (0.343, 1.412)
Anti-Jo-1(+) >0.999 <0.001
CA125 ≥35 U/ml 0.876 1.100 (0.331, 3.660)
CA19-9 ≥37 U/ml 0.042a 2.672 (1.034, 6.902) 0.319 1.811 (0.563, 5.824)

Notes.

OR
odds ratio
CI
confidence interval
a

P < 0.1.

*

P < 0.05, statistically significant difference.